; and (B) committed to ending the epidemic in all countries, and pledge[d] to provide leadership and to work together to accelerate our national and global collective actions, investments and innovations urgently to fight this preventable and treatable disease , as reflected in United Nations General Assembly Resolution 73/3. (11) The United States Government continues to be a lead funder of global TB research and development, contributing 44 percent of the total $915,000,000 in global funding in 2020, and can catalyze more investments from other countries. (12) Working with governments and partners around the world, USAID’s TB programming has saved an estimated 74,000,000 lives, demonstrating the effectiveness of United States programs and activities against the illness. (13) On September 26, 2018, the USAID Administrator announced a new performance-based Global Accelerator to End TB, aimed at catalyzing investments to meet the treatment target set by the United Nations High-Level Meeting, further demonstrating the critical role that United States leadership and assistance plays in the fight to eliminate TB. (14) It is essential to ensure that efforts among United States Government agencies, partner nations, international organizations, nongovernmental organizations, the private sector, and other actors are complementary and not duplicative in order to achieve the goal of ending the TB epidemic in all countries. 3. United States Government assistance to combat tuberculosis Section 104B of the Foreign Assistance Act of 1961 ( 22 U.S.C. 2151b–3 ) is amended to read as follows: 104B. Assistance to combat tuberculosis (a) Findings Congress makes the following findings: (1) The international spread of tuberculosis (referred to in this section as TB ) and the deadly impact of TB’s continued existence constitutes a continuing challenge. (2) Additional tools and resources are required to effectively diagnose, prevent, and treat TB. (3) Effectively resourced TB programs can serve as a critical platform for preventing and